Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes

Frontiers in Immunology(2021)10.3389/fimmu.2021.669986Source: DataRank Database

Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.30)OA: goldTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

John W. Kappler ORCID,Brendan Reed ORCID

Live enrichment

PubMed:33986758 PMC:PMC8111216 OpenAlex:https://openalex.org/W3157262354

NIAID NIH HHS

Grant: P01 AI118688

NIAID NIH HHS

Grant: T32 AI074491

National Institutes of Health

Grant: 5P01AI118688-02

Disruption of T cell tolerance in type 1 diabetes

National Institutes of Health

Grant: 5T32AI074491-12

Molecular Mechanisms of Immune Tolerance

Howard Hughes Medical Institute

National Jewish Health

FWCI

0.30

Citation Percentile

0.6%

Citation Trend

2022

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.669986/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.669986/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.669986/full

journalhttps://doi.org/10.3389/fimmu.2021.669986

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33986758

Fields of Study

Diabetes and associated disordersT-cell and B-cell ImmunologyImmune Cell Function and Interaction0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHistocompatibility Antigens Class IIAutoimmune DiseasesDiabetes Mellitus, Type 1HumansIslets of LangerhansPeptide FragmentsPeptidyl TransferasesCD4-Positive T-LymphocytesAutoimmunityAntigen PresentationEpitopes, T-Lymphocyte

Keywords

EpitopeBiologyAntigenT cellProteolysisReverse vaccinologyComputational biologyBeta cellImmunologyCell biologyImmune systemInsulinBiochemistryEndocrinologyImmune toleranceTranspeptidationType 1 diabetes mellitusChimeric peptideAntigen presenting cellCd4 T CellCD4-Positive T-LymphocytesAntigen PresentationHistocompatibility Antigens Class IIEpitopes, T-LymphocyteAutoimmunityRC581-607Peptide FragmentsAutoimmune DiseasesIslets of LangerhansDiabetes Mellitus, Type 1Peptidyl TransferasesAnimalsHumansImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being